The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia

Advancing cure rates for high-risk acute lymphoblastic leukemia (ALL) has been limited by the lack of agents that effectively kill leukemic cells, sparing normal hematopoietic tissue. Molecular glues direct the ubiquitin ligase cellular machinery to target neosubstrates for protein degradation. We d...

Celý popis

Podrobná bibliografia

Vydané v:	Blood Ročník 142; číslo 7; s. 629
Hlavní autori:	Chang, Yunchao, Keramatnia, Fatemeh, Ghate, Pankaj S, Nishiguchi, Gisele, Gao, Qingsong, Iacobucci, Ilaria, Yang, Lei, Chepyala, Divyabharathi, Mishra, Ashutosh, High, Anthony A, Goto, Hiroaki, Akahane, Koshi, Peng, Junmin, Yang, Jun J, Fischer, Marcus, Rankovic, Zoran, Mullighan, Charles G
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 17.08.2023
Predmet:	Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Child Humans Isoindoles - therapeutic use Piperidones - therapeutic use Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
ISSN:	1528-0020, 1528-0020
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!